Summary. A nation-wide Rh prevention programme was started in Finland in 1969. Before that, a control series of approximately 1000 Rh-negative mothers giving birth to an Rh-positive child was collected to estimate the number ofmothers with antibodies at either three, six, or nine months post partum. During the threeand-a-half year period altogether 14,980 Rh-negative patients were given 250 ,tg of anti-D immunoglobulin prepared from Finnish raw material in the Central Laboratory of the Dutch Red Cross. Out of those treated before the end of June 1972, 12,720 (97%,/) were tested four to six months post partum. Seventeen or 0.13% had detectable antibodies; in five of them the infant was ABO incompatible. The number of protected mothers with a subsequent Rh-positive infant was 1017; 10 had formed antibodies before the delivery of the second child.
The risk of primary immunization initiated during a single pregnancy was estimated to be 0.35o/. In addition, there was approximately a 0 60% risk of forming antibodies by the next Rh-positive pregnancy. The effect of prevention on the prevalence of haemolytic disease was calculated and compared with observed figures.
The preventive effect of the administration of anti-D immunoglobulin is well documented. (Combined study from Centres in England and Baltimore, 1971; WHO Scientific Group, 1971; Woodrow et al, 1971; Clarke, 1972; Clarke and McConnell, 1972 .) The failure incidence varies between 0 0 and 0.6% (Schneider, 1971 ). The evidence is mainly derived from comparisons with a large series of post-delivery control samples. The possible boosting effect of an additional Rh-positive child during the next pregnancy has so far only been studied in rather limited series (Woodrow, 1970; Schneider, 1971; Woodrow et al, 1971) . With a few exceptions (Zipursky and Israels, 1967; Godel et al, 1968; Buchanan et al, 1969 ; V. J. Freda and J. G. Gorman in Journal of Reproductive Medicine, 1971 ) the reports pay little or no attention to the group of patients excluded from prevention due to antibody formation before the delivery.
The purpose of this report is to present the results of a national Rh prevention programme including Received 23 November 1972. more than 12,000 patients followed up four to six months after delivery and more than 1000 of these who, after the administration of anti-D immunoglobulin, gave birth to another Rh-positive child. The results were analysed in order to compare the observed with the expected risk of immunization and to predict the effect of prevention on the incidence of haemolytic disease in the future. Other details of possible theoretical and practical importance are discussed. (Table I ). This is somewhat smaller than reported elsewhere; however, the collaborative German study reports an incidence of anti-Rh four to seven months after delivery of 3 8% (89/2330) and the Dutch figure is 5-2% (Schneider, 1971) .
Control Series
Neither of these is significantly different from ours.
Protected Series Anti-D Immunoglobulin. It should be remembered that, apart from negligence, there is a group of mothers who are not protected because of the presence of antibodies at delivery. In addition, protection was omitted in an unknown number of cases due to sterilization or some other reason.
Blood Typing and Clerical Errors. The double investigation made it possible to register the results that differed in the local hospital and in our Failures. In the broader sense failure refers to all Rh-negative mothers who formed antibodies during the programme. From the point of view of both mother and the community it is immaterial whether antibodies are formed after the administration of anti-D immunoglobulin or before. The Canadians and the Australians have already paid attention to both groups (Zipursky and Israels, 1967; Buchanan et al, 1969; Bowman, 1970 (Table VI) . As the primiparae represent approximately one half of the total series, the number of Total 46 double that of the primiparae, a similar pattern to that observed in the whole group of 106 patients discussed above.
The Risk of Immunization The following calculation is based on information on all the immunized mothers in Finland obtained from the four district laboratories responsible for the compulsory screening of all pregnant women. The figures for 1969 are the last not to have been influenced by the preventive programme. In 1969, altogether 165 newly immunized mothers were observed. This group includes 18 mothers with an Rh-negative child; the other children were Rhpositive. In all the cases antibodies were detected four weeks before delivery and accordingly the group of 'late' antibody formers discussed above is not included.
The risk of immunization within six months of delivery in our control series was 3-5%. Applying this to the figures obtained from the total number of births and parity distribution in 1969 with known gene frequencies of D and d, we obtain the total number of Rh-negative mothers delivering two consecutive children. This information is presented in Table VIII . These include all the children born to homozygous fathers and to a quarter of those born to heterozygous fathers. Also in Table VIII are the figures for the Rh-negative mothers who gave birth to an Rh-negative child after an Rh-positive baby; this group represents one quarter of those children born of heterozygous fathers. In the last column of Table VIII is the number of observed newly immunized mothers delivered in 1969.
The expected and observed number of immunized mothers giving birth to an Rh-negative child are close: 18 and 15-8, respectively. Conversely, there is a large surplus of observed immunized mothers giving birth to an Rh-positive child. The fact that the observed number is almost double that anticipated must depend on the secondary immune response. In other words, it seems that only about one half of the immunized mothers will be detected when the investigation is made six months after the last delivery.
The Effect of Prevention on the Prevalence of Haemolytic Disease of the Newborn Although practically every Rh-negative mother delivering an Rh-positive child is protected now, the clinical effect of the programme on the number of new cases of immunization is far from its final goal. In order to estimate the proportion of mothers who (Table I) .
deliver an Rh-positive child and who were not protected in connection with delivery of the next to last Rh-positive child, the total number of mothers at risk is first calculated using the total number of births in each year, the parity distribution as well as the known proportion of homozygotes and heterozygotes in the population. The risk group is formed by all the Rh-negative mothers who give birth to two consecutive Rh-positive infants in each year. This condition is fulfilled in all children with homozygous (4326 o6) and in a quarter with heterozygous fathers (4 of 4503 or 11-26o). In 1969 this group was 67,500 x 0-1172 x 05452 x 0-4711 (proportion of the multiparae) or 2032.
In each year the number of mothers protected twice is compared with total group at risk. The result in periods of three months is presented in Fig. 1 which shows that in the last quarter one half (47-60o) of the population at risk has still been delivered without protection in connection with the delivery of their former Rh-positive child. For comparison, the new cases of Rh-immunization observed between 1969 and 30 June 1972, are presented as a percentage of the 1969 figures. These are corrected according to the number of births, assuming that the parity distribution has remained unchanged.
Discussion
The immunization rate following a single pregnancy with an ABO-compatible, Rh-positive infant in the control series of approximately 1000 Rhnegative women was lower than in the series reported elsewhere and especially in England. The failure rate in our controlled trials is among the lowest so far reported. The recent report of the Collaborative RhoGAM study, however, shows that only 5 out of 3241 or 0-15%,o of the treated mothers de- Table VII ) there were in all 21 such cases out of 12,720 (0-16%xO) which would more than double the actual failure rate (Schneider, 1971 (Woodrow et al, 1971; Schneider, 1971 ). In our series of treated mothers the great majority of failures appeared as a secondary immune response due to the next Rh-positive pregnancy, ie, 10/1027 compared to 17/12,720 or 1-0%. and 0*13%, respectively. The pattern of immunization thus seems to be different from that seen in untreated control series, where approximately half of the immunized mothers form antibodies after the first observed pregnancy, as reported by Ascari, Levine, and Pollack (1969) and Woodrow and Donohoe (1968) , or calculated indirectly from the clinical series. With the very low failure rate (0-13 %) in the post-delivery controls in the present series, the difference was more distinct than in other series reported from elsewhere (Schneider, 1971) . However, the number of antibody producers due to a secondary stimulus is at least twice that in the controls after delivery. There is every reason, therefore, to increase the series with multiple pregnancies, a goal which enlarged our series far beyond the size needed for evaluation of the effect of prevention in the post-partum sample only. The incidence of Rh-immunization by a single pregnancy before delivery was higher than the post-partum failure rate or 0-35 % when estimated from the group of primiparae, but much lower than that reported from Canada (Bowman 1970) . The fact that antibodies were present at delivery twice as frequently in the multiparae is difficult to explain without assuming that half of this group represents a primary and not a secondary response.
In the future, the different rates in primi-and multiparae should decrease and finally disappear when all mothers are treated. Still, primary immunization initiated during a single pregnancy forms a problem which seems to be at least as large as that of the dose effect. Although we have no experience of treatment before delivery, the importance of the series now in progress in Canada and Australia deserves emphasis.
Years ago, we used the ABO constellation as a marker to locate the pregnancy inducing the primary sensitization or, to use the old term, sensibilization (Nevanlinna, 1952 and 1953; Ne-vanlinna and Vainio, 1956) . In the present series, the ABO constellation has some aspects of interest which might throw light on the mechanism of immunization as well as protection. We see once again in our control series that ABO incompatibility protects well against primary sensibilization and immunization, but gives poor if any protection to the mother against secondary stimulus (Woodrow, 1970 The present results show that more complete protection can be expected only by starting a programme of ante-partum Rh prophylaxis for all Rh-negative women at risk. There is no doubt that this approach is justified as a clinical trial in as many research centres as possible to obtain the data required to determine the timing and dosage of anti-D IgG given during pregnancy.
